MBL-HCV1
/ MassBiologics
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 24, 2014
High-throughput sequencing analysis of post-liver transplantation HCV e2 glycoprotein evolution in the presence and absence of neutralizing monoclonal antibody
(PLoS One)
- P2, N=11; NCT01121185; Sponsor: MassBiologics "Evaluation of mutations along the entire E1 and E2 proteins revealed additional positions that changed moderately before and after MBL-HCV1 treatment for subsets of the six subjects, yet underscored the relative importance of position 415 in MBL-HCV1 resistance."
P2 data • Hepatitis C Virus
1 to 1
Of
1
Go to page
1